Search filters

List of works by John A. Lust

A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing

scientific article published on 13 February 2019

A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma

scientific article

A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?

scientific article published on June 2013

A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death.

scientific article

A novel report of cig-FISH and cytogenetics in POEMS syndrome.

scientific article

A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

scientific article published in January 2005

A phase II trial of imatinib in patients with refractory/relapsed myeloma

scientific article published on January 2006

A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma

scientific article published on 20 August 2012

A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy

scientific article published on 18 January 2007

A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine

scientific article published on 01 April 1997

ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells.

scientific article published on 26 April 2007

Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death.

scientific article published on May 2015

Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma

scientific article published on 01 September 1999

Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis

scientific article

Analysis of Clinical Factors and Outcomes Associated with Non-Utilization of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant Eligible Patients with Multiple Myeloma

scientific article published on 12 April 2018

Aplastic anemia and pure red cell aplasia associated with large granular lymphocyte leukemia

scientific article

Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature

scientific article published on 20 July 2010

Autologous stem cell transplantation for relapsed and primary refractory myeloma

scientific article published on 01 June 1999

Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation

scientific article published on 12 October 2016

Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma

scientific article published on 01 June 1999

Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis

scientific article published on 25 February 2020

Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis

scientific article published on 01 July 2002

Bone marrow angiogenesis in multiple myeloma: effect of therapy

article

Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

scientific article published on 22 November 2019

CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line.

scientific article published on January 1994

Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma

scientific article published on 16 June 2017

Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma

scientific article published on 28 August 2020

Characterization and prognostic implication of delayed complete response in AL amyloidosis

scientific article published on 23 November 2020

Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma

scientific article published on 01 February 2003

Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosis

scientific article published on 05 September 2002

Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma

scientific article published on 16 June 2005

Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma

scientific article

Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies

scientific article published on 5 May 2016

Clinical characteristics and outcomes in biclonal gammopathies

scientific article published on 3 February 2016

Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities

scientific article published on 01 August 2020

Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy

scientific article published on 11 April 2016

Clinical course of patients with relapsed multiple myeloma

scientific article published in July 2004

Clinical implication of centrosome amplification in plasma cell neoplasm

scientific article published on 22 December 2005

Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.

scientific article published on 29 April 2009

Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains

scientific article published on 18 September 2017

Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia

scientific article published on 29 March 2017

Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?

scientific article published on 01 September 1994

Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma

scientific article published on 17 February 2017

Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications

scientific article published on November 1993

Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis

scientific article published on 21 October 2013

Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatment

scientific article published on 06 October 2020

Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma

scientific article published on 23 August 2005

Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial

scientific article

Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma

scientific article published in November 2002

Comparative analysis of staging systems in AL amyloidosis

scientific article published on 23 January 2019

Comparison of interleukin-1 beta expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myeloma

scientific article

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.

scientific article published on 25 October 2013

Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myeloma ⬇️

scientific article published on 01 April 1998

Correction: Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

scientific article published on 29 July 2020

Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients

scientific article published on 11 December 2020

Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy

scientific article published on 09 October 2019

Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response

scientific article published on 11 August 2020

Cytokine and chemokine profiles in multiple myeloma; significance of stromal interaction and correlation of IL-8 production with disease progression

scientific article published on 01 August 2006

Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progression

article

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria

scientific article published on 20 February 2018

Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria

scientific article published on 01 January 2019

Development of thrombocytopenia during first-line treatment and survival outcomes in newly diagnosed multiple myeloma

scientific article published on 16 May 2019

Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia

scientific article published on 08 August 2017

Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.

scientific article published on 05 January 2017

Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines

scientific article

Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice

scientific article

Differential expression of vascular endothelial growth factors and their receptors in multiple myeloma.

scientific article

Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs

scientific article published on October 2010

Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma

scientific article published on 01 February 1999

Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents

scientific article

Effect of complete response on outcome following autologous stem cell transplantation for myeloma

scientific article published on 01 November 2000

Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma.

scientific article published in March 2004

Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myeloma

scientific article published on 25 October 2017

Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials

scientific article published on 11 August 2017

Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma

scientific article

Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation

scientific article

Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival

scientific article published in July 2001

Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays

scientific article

Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells

scientific article published on 08 January 2020

Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial.

scientific article

Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6.

scientific article published on May 1996

Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma

scientific article published on 29 July 2016

Expression of CD52 on plasma cells in plasma cell proliferative disorders ⬇️

scientific article published on April 24, 2003

Flow cytometric assessment of TCR-Vbeta expression in the evaluation of peripheral blood involvement by T-cell lymphoproliferative disorders: a comparison with conventional T-cell immunophenotyping and molecular genetic techniques

scientific article published in March 2004

Genomic abnormalities in monoclonal gammopathy of undetermined significance

scientific article published on 01 August 2002

Glycosylation of Immunoglobulin Light Chains is Highly Prevalent in Cold Agglutinin Disease

scientific article published on 01 May 2020

Hematology patient reported symptom screen to assess quality of life for AL amyloidosis

scientific article published on 9 February 2017

High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis

scientific article published on 08 January 2014

High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy

scientific article

IL-1beta expression in IgM monoclonal gammopathy and its relationship to multiple myeloma

scientific article published on 01 March 2002

Identification of two groups of smoldering multiple myeloma patients who are either high or low producers of interleukin-1.

scientific article published on February 2006

Immunoglobulin D amyloidosis: a distinct entity

scientific article published on 07 November 2011

Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases

scientific article published on 01 November 1994

Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias

scientific article published on 02 September 2014

Immunoglobulins and Laboratory Recognition of Monoclonal Proteins

Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

scientific article published on 23 May 2016

Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen type

Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type

scientific article published on 16 June 2016

Impact of acquired del(17p) in multiple myeloma

scientific article published on 01 July 2019

Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma

scientific article published on 21 October 2015

Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL).

scientific article published on 27 September 2017

Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma

scientific article published on 21 March 2013

Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma

scientific article published on 20 February 2019

Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis

scientific article published on 21 December 2017

Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone

scientific article published on 26 March 2009

Implications and outcomes of MRD-negative multiple myeloma patients with immunofixation positivity

scientific article published on 30 December 2019

Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma

scientific article published on 02 October 2020

Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma

scientific article

Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death

scientific article published on 26 January 2017

Improved survival in multiple myeloma and the impact of novel therapies

scientific article

Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma

scientific article

Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains

scientific article published on 2 April 2008

In Reply

Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis

scientific article published on 01 May 2018

Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component

scientific article published on February 2009

Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation

scientific article published on 24 June 2016

Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category

scientific article

Intestinal lymphangiectasia with protein-losing enteropathy in Waldenstrom macroglobulinemia

scientific article published on July 2007

Intracardiac thrombosis and embolism in patients with cardiac amyloidosis

scientific article published on 05 November 2007

Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor ⬇️

scientific article published on March 1, 1992

Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis

scientific article published on 16 January 2015

Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients

scientific article

Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial

scientific article published on 31 May 2011

Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial

scientific article

Localized tongue amyloidosis: a single institutional case series.

scientific article published on 28 May 2013

Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy

scientific article published on 18 February 2014

Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience

scientific article published on 11 March 2016

Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis

scientific article published on 08 January 2020

Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma

scientific article published in October 2007

Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma

scientific article

Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light-chain amyloidosis

scientific article published on 18 July 2008

Long-term survival (10 years or more) in 30 patients with primary amyloidosis

scientific article published on 01 February 1999

Lymphoproliferative disease of granular T lymphocytes presenting as aplastic anemia

scientific article published on 01 November 2000

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines

scientific article published on December 2009

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.

scientific article published on April 2013

Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma

scientific article published on August 2006

Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma

scientific article published on 01 May 2020

Methods for estimation of bone marrow plasma cell involvement in myeloma: Predictive value for response and survival in patients undergoing autologous stem cell transplantation

article

Modulation of eIF5A Expression Using SNS01 Nanoparticles Inhibits NF-κB Activity and Tumor Growth in Murine Models of Multiple Myeloma ⬇️

scientific article published on May 15, 2012

Molecular and biological role of CD40 in multiple myeloma

scientific article published on 01 January 1995

Monoclonal gammopathies and associated skin disorders

scientific article

Monoclonal gammopathies of undetermined significance

scientific article published on 01 July 1989

Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis

scientific article published on 27 February 2019

Myelomatous Involvement of the Central Nervous System

scientific article

N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma

scientific article published on 10 August 2016

Natural history of multiple myeloma with de novo del(17p)

scholarly article by Arjun Lakshman et al published 7 March 2019 in Blood Cancer Journal

Natural history of t(11;14) multiple myeloma

scientific article

Natural history of thromboembolism in AL amyloidosis

scientific article

Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma

scientific article published on 11 March 2016

Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker

scientific article published on 14 November 2002

Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio

scientific article published on 26 September 2018

Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant

scientific article published on 2 March 2014

Outcomes of patients with POEMS syndrome treated initially with radiation

scientific article

Outcomes of patients with renal monoclonal immunoglobulin deposition disease

scientific article published on 8 August 2016

Outcomes of primary refractory multiple myeloma and the impact of novel therapies

scientific article published on 27 July 2015

Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma

scientific article published on 12 March 2019

Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosis

scientific article published on 09 June 2020

Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome

scholarly article by Ashley R Paquin et al published 11 December 2018 in Blood Cancer Journal

Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition

scientific article published on 8 March 2017

POEMS syndrome: definitions and long-term outcome

scientific article

Periodic fever syndrome with relapsing glomerulonephritis: a case report and teaching points

scientific article

Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma

scientific article published on 13 December 2018

Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma.

scientific article published on September 1996

Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma

scientific article published on 30 July 2018

Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis

scientific article published in June 1999

Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis

scientific article published on 01 July 1999

Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma

scientific article published on 01 June 1993

Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response

scientific article published on 07 August 2018

Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myeloma

scientific article published in October 2003

Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM).

scientific article

Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma

scientific article

Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease

scientific article published on 20 June 2011

Pomalidomide, Bortezomib and Dexamethasone (PVD) for Patients with Relapsed, Lenalidomide Refractory Multiple Myeloma

scientific article

Pomalidomide-dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trial

scientific article published on September 2017

Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis

scientific article published in December 2003

Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myeloma

scientific article published on 6 July 2015

Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosis

scientific article

Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience

scientific article published on 5 May 2017

Prevalence and predictors of thyroid functional abnormalities in newly diagnosed AL amyloidosis

scientific article published on 24 April 2017

Primary follicular mucinosis: long-term follow-up of patients younger than 40 years with and without clonal T-cell receptor gene rearrangement

scientific article published on 01 December 2002

Prognostic Value of Circulating Plasma Cells in Monoclonal Gammopathy of Undetermined Significance

article

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma

scientific article published in September 2017

Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia

scientific article

Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis

scientific article published on 21 February 2018

Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance

scientific article published on 30 January 2018

Prognostic value of angiogenesis in solitary bone plasmacytoma

scientific article published on 17 October 2002

Prognostic value of bone marrow angiogenesis in multiple myeloma

scientific article published on 01 August 2000

Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy.

scientific article published in August 2004

Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy

scientific article published on 30 April 2019

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

scientific article published on 25 March 2004

Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis

scientific article published on 01 January 1999

Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression

scientific article published on 26 July 2016

R-(-)-gossypol (AT-101) activates programmed cell death in multiple myeloma cells.

scientific article published on 17 March 2008

Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method

scientific article published on 08 January 2019

Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score

scientific article

Reduction in C-reactive protein indicates successful targeting of the IL-1/IL-6 axis resulting in improved survival in early stage multiple myeloma

scientific article published on 06 March 2016

Reduction in plasma cell proliferation after initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survival

scientific article published on 12 July 2011

Refining amyloid complete hematological response: quantitative serum free light chains superior to ratio

scientific article published on 18 July 2020

Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma

scientific article published in January 2003

Review of 1027 patients with newly diagnosed multiple myeloma

scientific article

Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma

scholarly article by Praful Ravi et al published 15 November 2018 in Blood Cancer Journal

Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements

scientific article published on 13 February 2012

Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment

scientific article published on 16 December 2015

Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria.

scientific article

Screening panels for detection of monoclonal gammopathies

scientific article published on 11 June 2009

Sequence, expression and function of an mRNA encoding a soluble form of the human interleukin-6 receptor (sIL-6R).

scientific article published on January 1995

Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: when is the optimal time for stem cell harvest?

scientific article published on 01 November 1995

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis

scientific article published in September 2004

Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein

scientific article published on 15 August 2018

Short communication: Absence of evidence of HTLV-3 and HTLV-4 in patients with large granular lymphocyte (LGL) leukemia

scientific article

Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma

scientific article published on 01 September 2004

Smoldering multiple myeloma requiring treatment: time for a new definition?

scientific article

Specificity of Serum and Urine Protein Electrophoresis for the Diagnosis of Monoclonal Gammopathies

scientific article published on 15 September 2010

Stem cell transplantation compared with melphalan plus dexamethasone in the treatment of immunoglobulin light-chain amyloidosis

scientific article published on 03 May 2016

Substratification of patients with newly diagnosed standard-risk multiple myeloma

scientific article published on 15 February 2019

Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study

scientific article published on 22 January 2004

Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosis

scientific article published on 23 September 2019

Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome

scientific article published on October 2016

Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma

scientific article published on 19 March 2013

T-cell non-Hodgkin lymphoma in human immunodeficiency virus-1-infected individuals

scientific article published in July 1989

Ten-year survivors in AL amyloidosis: characteristics and treatment pattern

scientific article published on 12 July 2019

Thalidomide as initial therapy for early-stage myeloma

scientific article published in April 2003

Thalidomide for previously untreated indolent or smoldering multiple myeloma

scientific article published in August 2001

Thalidomide in the treatment of relapsed multiple myeloma

scientific article published on 01 September 2000

The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis

scientific article

The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation

scientific article published on 30 November 2015

The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma

scientific article published on 31 May 2017

The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment

scientific article

The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?

scientific article published on 06 May 2020

The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome

scientific article published on 31 August 2011

Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy

scientific article published on 10 March 2017

Time to plateau as a predictor of survival in newly diagnosed multiple myeloma.

scientific article published on 16 April 2018

Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.

scientific article published on 11 February 2009

Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis

scientific article published on 01 October 2001

Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement

scientific article published on August 2015

Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement

scientific article published on March 2007

Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosis

scientific article published on 17 March 2017

Trends and outcomes of modern staging of solitary plasmacytoma of bone

scientific article published on 2 May 2012

Trends in survival of patients with primary plasma cell leukemia: a population-based analysis

scientific article

Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics

scientific article published on 10 January 2012

Unusual presentation of extranodal peripheral T-cell lymphomas with multiple paraneoplastic features

scientific article published on August 1991

Utility of repeating bone marrow biopsy for confirmation of complete response in multiple myeloma

scientific article published on 02 October 2020

Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy

scientific article

Utility of serum free light chain ratio in response definition in patients with multiple myeloma

scientific article published on 01 January 2020

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement.

scientific article

Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia

scientific article published on 04 March 2020

Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil

scientific article published on March 2000

Paulina is supported by:

About Paulina

Help